The Food and Drug Administration (FDA) issued a guidance document in January 2021 to provide recommendations to prospective applicants of abbreviated new drug applications (ANDAs) on ensuring the protection of participants when resuming or initiating bioequivalence...
Renzo DiCarlo, CEO of BioPharma Services Inc. was proud to be invited to appear as a witness before the House of Commons’ Standing Committee on International Trade, in view of its study entitled Canada’s International Trade and Investment Policy: Selected...
BioPharma Services CEO Renzo DiCarlo spoke to Brian Crombie, host of the popular radio show 'The Brian Crombie Radio Hour' on Sauga 960 AM. During the conversation, Renzo shared his experience leading BioPharma during the COVID-19 pandemic. He also spoke about the...
Throughout this pandemic we’ve all had to find new ways of working and supporting each other. BioPharma Services has been proud to provide COVID-19 testing services for Private Eyes, the Golden Screen Award-winning hit series starring Canada’s favourite detective duo...
The US Food and Drug Administration (FDA) has posted a number of new or revised Product-Specific Guidances for Bioequivalence Drug Development. The Guidances cover a wide range of drugs and also complex products such as Metered Dose Inhalers (MDI). With over 2000...
BioPharma Services Inc., since the early days of the COVID-19 or Coronavirus pandemic, has followed stringent safety guidelines recommended by public health departments in both Canada and the USA. Our premises were renovated and we operated with reduced in-house staff...